Rene Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Rene Pharmaceuticals Private Limited

Rene Pharmaceuticals Private Limited, a active private limited company, was established on 17 March 2016 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51101MH2016PTC274524. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Employing 27 professional, Its leadership includes Narendra Parshuram Shelar (Managing Director), Nalamati Arun (Director). Past directors included Ammanna Nalamati, Madanmohan Fatehbir Bahadur, Nalamati Arun. It holds ₹2.32 Cr open charges and ₹3.30 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 206 Dimple Arcade Extension Building 10 Asha Nagar, Kandivali East, Mumbai, Maharashtra, 400101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51101MH2016PTC274524

  • Registration Number

    274524

  • Incorporation Date

    17 March 2016

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 10 Year, 9 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.32 Cr
  • Satisfied Charges ₹ 3.30 Cr
  • Revenue Growth **** -23.29%
  • Profit Growth **** -19.20%
  • Ebitda **** -27.02%
  • Net Worth 17.92%
  • Total Assets -2.57%
Company report

Rene Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rene Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rene Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Narendra Parshuram Shelar Managing Director 17 Mar 2016 Current
Nalamati Arun Director 23 Aug 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Aug 2016 Past
Pramod Abcsdd Director 25 Aug 2016 Past
Pramod Abcsdd Additional Director 24 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rene Pharmaceuticals.

Rene Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.29% decrease. The company also saw a substantial fall in profitability, with a 19.2% decrease in profit. The company's net worth Soared by an impressive increase of 17.92%.

Rene Pharmaceuticals revenue growth over time
Rene Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -23.29%
*******
*******
*******
*******
Revenue from Operations
*******
 -24.11%
*******
*******
*******
*******
Total Assets
*******
 -2.57%
*******
*******
*******
*******
Profit or Loss
*******
 -19.20%
*******
*******
*******
*******
Net Worth
*******
 17.92%
*******
*******
*******
*******
EBITDA
*******
 -27.02%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rene Pharmaceuticals?

In 2022, Rene Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹23,162,884.00

Satisfied Charges

₹33,000,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 2.00 Cr
  • Hdfc Bank Limited : 0.32 Cr
Latest Charge Details
Date Lender Amount Status
05 Jan 2024 Axis Bank Limited ₹2.00 Cr Open
21 Oct 2023 Hdfc Bank Limited ₹3.16 M Open
25 Jan 2022 Axis Bank Limited ₹1.65 Cr Satisfied
21 Jan 2022 Axis Bank Limited ₹1.65 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Rene Pharmaceuticals?

Rene Pharmaceuticals has a workforce of 27 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rene Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rene Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rene Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Rene Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Rene Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was documented.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 20.00 M with Charge ID 100870174 was registered on 05 Jan 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 3.16 M with Charge ID 100856719 was registered on 21 Oct 2023. was documented.

  • Charges

    Progress on A charge registered on 25 Jan 2022 via Charge ID 100547754 with Axis Bank Limited was fully satisfied on 01 Feb 2023. was documented.

  • Charges

    A charge registered on 21 Jan 2022 via Charge ID 100547755 with Axis Bank Limited was fully satisfied on 01 Feb 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rene Pharmaceuticals Private Limited?

The CIN of Rene Pharmaceuticals Private Limited is U51101MH2016PTC274524.

Where is Rene Pharmaceuticals Private Limited headquartered?

Rene Pharmaceuticals Private Limited is headquartered at 206 Dimple Arcade Extension Building 10 Asha Nagar, Kandivali East, Mumbai, Maharashtra, 400101.

When was Rene Pharmaceuticals Private Limited incorporated?

Rene Pharmaceuticals Private Limited was incorporated on 17 March 2016.

Who are the current directors of Rene Pharmaceuticals Private Limited?

The current directors of Rene Pharmaceuticals Private Limited are

What is the primary industry of Rene Pharmaceuticals Private Limited?

The primary industry of Rene Pharmaceuticals Private Limited is Trade.

Is Rene Pharmaceuticals Private Limited a listed company?

Rene Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Rene Pharmaceuticals Private Limited?

The authorized capital of Rene Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Rene Pharmaceuticals Private Limited?

The compliance status of Rene Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available